Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Samsung Electronics Co., Ltd.
  6. News
  7. Summary
    A005930   KR7005930003

SAMSUNG ELECTRONICS CO., LTD.

(A005930)
  Report
End-of-day quote Korea Stock Exchange  -  2023-01-26
64600.00 KRW   +1.10%
01/29South Korean shares start week lower; Fed, Samsung earnings in focus
RE
01/29Samsung Electronics : Achieves Life Cycle Assessment Verification on Product Carbon Footprint for Semiconductors
PU
01/27Samsung Electronics DS Division Obtains ISO Certification for its Business Continuity Management System
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

NeuroLogica Announces FDA 510 Clearance of BodyTom 64

11/29/2022 | 10:11am EST

NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced that its head-to-toe trauma imaging solution, the BodyTom 64 Point-of-Care Mobile Computed Tomography (CT) Scanner, has received 510(k) clearance from the U.S. Food and Drug Administration for commercial use in the United States.

We're thrilled to build off our expertise and elevate point-of-care imaging with our BodyTom 64, which can transform any room in a hospital into an advanced imaging suite,' said Jason Koshnitsky, Sr. Director of Global Sales and Marketing of NeuroLogica. 'This full-body 64-slice CT scanner is an upgraded version of the BodyTom Elite CT scanner, providing enhanced functionality with the same high-resolution imaging capabilities.'

Based on customer feedback, the company designed the BodyTom 64 to enhance the user experience and improve clinical workflows through revisions to both the software and the data acquisition system (DAS). Such revisions include incorporating Linux as the operating system and having the ability to generate up to 64 cross-sectional CT images of a patient's body, versus the 32 images produced by the predicate BodyTom Elite.

With indications for both pediatric and adult imaging, the BodyTom 64 is a multi-departmental imaging solution that can be utilized for various needs, including: Neurosurgery/Surgery: When combined with any radiolucent skull fixation device, the BodyTom 64 can transform an operating room into an intraoperative neuro-imaging suite to enhance neuro-navigation and surgical outcomes, including clinical utility for extracranial procedures.

Trauma/ER: The BodyTom 64's unique combination of internal lead shielding and battery operation allows any standard trauma bay to be transformed into an advanced CT imaging suite.

Interventional Radiology: BodyTom 64 can help optimize workflows by remaining ready to rescan for each stage of needle guidance, and bring the power of multi-slice CT to the interventional suite.

The BodyTom 64 brings the power of innovative imaging to patients' bedsides safely and efficiently. BodyTom 64 is designed and manufactured to comply with the FDA Quality System Regulations and ISO 13485:2016 requirements and is in conformance with global regulatory harmonized standards.

About NeuroLogica

NeuroLogica Corp., the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica is the global corporate headquarters and manufacturer of mobile computed tomography devices. NeuroLogica's growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency.

Contact:

Jason Koshnitsky

Tel: 508.904.3819

Email: jkoshnitsky@neurologica.com

(C) 2022 Electronic News Publishing, source ENP Newswire

All news about SAMSUNG ELECTRONICS CO., LTD.
01/29South Korean shares start week lower; Fed, Samsung earnings in focus
RE
01/29Samsung Electronics : Achieves Life Cycle Assessment Verification on Product Carbon Footpr..
PU
01/27Samsung Electronics DS Division Obtains ISO Certification for its Business Continuity M..
AQ
01/27Samsung SDS Logs 136% Jump in Q4 Income; Revenue Tops Estimates
MT
01/27South Korean Stocks End Week in the Green; Samsung SDS Rises 1% as Q4 Net Income Soars ..
MT
01/26South Korean shares set for fourth straight weekly gain
RE
01/26South Korean Stocks Close Higher for Fourth Day on Overseas Buying; Samsung Adds 1%, Hy..
MT
01/26South Korean Stocks Closes with Gains for Fourth Day on Overseas Buying
MT
01/26Samsung Electro-Mechanics' Q4 Income Surges 43%; Revenue Miss Estimates
MT
01/26Samsung Electronics' DS Division Obtains ISO Certification for its Business Continuity ..
AQ
More news
Analyst Recommendations on SAMSUNG ELECTRONICS CO., LTD.
More recommendations
Financials
Sales 2022 302 996 B 246 B 246 B
Net income 2022 35 372 B 28,7 B 28,7 B
Net cash 2022 111 346 B 90,4 B 90,4 B
P/E ratio 2022 12,0x
Yield 2022 2,25%
Capitalization 433 540 B 352 B 352 B
EV / Sales 2022 1,06x
EV / Sales 2023 1,12x
Nbr of Employees -
Free-Float 83,1%
Chart SAMSUNG ELECTRONICS CO., LTD.
Duration : Period :
Samsung Electronics Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SAMSUNG ELECTRONICS CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 39
Last Close Price 64 600,00 KRW
Average target price 75 051,28 KRW
Spread / Average Target 16,2%
EPS Revisions
Managers and Directors
Jong-Hee Han Vice Chairman & Co-Chief Executive Officer
Kye Hyun Kyung Co-Chief Executive Officer & Executive Director
Hee-Chan Roh Chief Financial Officer
Han-Jo Kim Chairman
Jae-Yong Lee Executive Chairman
Sector and Competitors